Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase EARLY_PHASE1 1Phase 1 1

Status

Completed 12Unknown 5Terminated 4Recruiting 4Active not recruiting 4Withdrawn 2Not yet recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 3

Conditions

Neoplasm Metastasis 2Breast Neoplasms 2Polycystic Ovary Syndrome 1Anatomic Stage III Breast Cancer AJCC v8 1

Interventions

Specimen Handling 336Magnetic Resonance Spectroscopy 333Radiotherapy 315Cyclophosphamide 295pembrolizumab 282Cisplatin 266Carboplatin 245Drug Therapy 237Blood Specimen Collection 233Biopsy 206Bevacizumab 187Gemcitabine 177venetoclax 172Radiosurgery 169Capecitabine 165Oxaliplatin 163fludarabine 160Nivolumab 156Paclitaxel 155Standard of Care 137Surveys and Questionnaires 131Surgical Procedures, Operative 130Dexamethasone 127Fluorouracil 125Docetaxel 113tislelizumab 110Rituximab 110Cytarabine 104atezolizumab 101Azacitidine 101

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Recruiting × OTHER × Estradiol × Clear all
NCT05716516 2026-05-05

ESTHER

Dartmouth-Hitchcock Medical Center

Phase 2 Recruiting
36 enrolled
Breast

Breast Neoplasms, Neoplasm Metastasis

NCT06179303 2026-04-16

Functional Imaging in Prediction of Response to Abemaciclib for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer

University of Washington

Phase 2 Recruiting
60 enrolled
Breast

Anatomic Stage III Breast Cancer AJCC v8

NCT05900895 2025-11-20

PHOEBE

Dartmouth-Hitchcock Medical Center

Phase 1 Recruiting
6 enrolled
Breast

Breast Neoplasms, Neoplasm Metastasis

NCT03401047 2025-08-05

CRM009

University of Virginia

Phase EARLY_PHASE1 Recruiting
37 enrolled

Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡